The National Drug Policy of 1982 enabled Bangladesh to achieve self-sufficiency in pharmaceutical production.
Bangladesh’s pharmaceutical industry is marred by exploitative practices that push employees to their limits and compromise ethical standards.
Rising production cost is the primary reason for the shrinking profits of pharma companies in Bangladesh
